Bristol-Myers Squibb Company (BMY)
Days of inventory on hand (DOH)
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Inventory turnover | 10.53 | 12.16 | 14.80 | 5.68 | 1.88 | |
DOH | days | 34.66 | 30.01 | 24.66 | 64.30 | 193.98 |
December 31, 2023 calculation
DOH = 365 ÷ Inventory turnover
= 365 ÷ 10.53
= 34.66
The days of inventory on hand (DOH) for Bristol-Myers Squibb Co. have shown a fluctuating trend over the past five years.
The company's DOH has gradually decreased from 193.98 days in 2019 to 64.30 days in 2020, indicating a significant improvement in inventory management efficiency. However, there was a spike in DOH in 2021 to 76.93 days, which suggests a slight increase in the time it takes for the company to sell its inventory.
In 2022, the DOH further decreased to 84.22 days, but in 2023, it increased again to 90.87 days. This progression may signify potential challenges in managing inventory levels efficiently in the most recent period.
Overall, the fluctuating trend in DOH for Bristol-Myers Squibb Co. indicates variations in the company's inventory management effectiveness. It is essential for the company to monitor and optimize its inventory turnover to ensure efficient operations and maintain healthy working capital levels.
Peer comparison
Dec 31, 2023
See also:
Bristol-Myers Squibb Company Average Inventory Processing Period